MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from maturities
of marketable...
$70,700K
Proceeds from exercises
of stock options
$685K
Net cash provided by
(used in) investing...
$43,993K
Net cash provided by
financing activities
$685K
Effect of exchange rate
changes on cash, cash...
$64K
Canceled cashflow
$26,707K
Net decrease in
cash, cash...
-$33,819K
Canceled cashflow
$44,742K
Long-lived asset
impairment charge
$30,886K
Stock-based compensation
expense
$7,655K
Depreciation expense
$4,280K
Accrued expenses and
other current...
$1,431K
Non-cash lease expense
$730K
Accounts receivable
-$727K
Other non-current
assets
-$270K
Loss on disposal of
property and equipment
-$63K
Purchases of marketable
securities
$26,189K
Purchases of property and
equipment
$518K
Net cash used in
operating activities
-$78,561K
Canceled cashflow
$46,042K
Net loss
-$117,260K
Accounts payable
-$2,311K
Prepaid expenses and
other current assets
$1,674K
Deferred revenue
-$1,590K
Operating lease
liabilities
-$1,279K
Net amortization of
premiums and discounts on...
$489K
Back
Back
Cash Flow
source: myfinsight.com
Korro Bio, Inc. (KRRO)
Korro Bio, Inc. (KRRO)